3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Dyspareunia
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
HIV Infections
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Bowen's Disease
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Fluorouracil
3
Watchful Waiting
2
Taxes
2
Polymerase Chain Reaction
2
Paclitaxel
2
Light Coagulation
2
Imiquimod
2
Cisplatin
2
Carboplatin
2
cabozantinib
1
Vorinostat
1
Triage
1
Specimen Handling
1
Remote Patient Monitoring
1
Radiotherapy
1
Radiation
1
Platinum
1
Observation
1
Nivolumab
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Laser Therapy
1
Isotretinoin
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Histological Techniques
1
Electrocoagulation
1
Coal Tar
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Laser Therapy
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts